ACT® U.S.A.

Adjustable Continence Therapy

CAUTION ­­ Investigational device. Limited by Federal (or United States) law to investigational use.

ACT is currently under clinical (IDE) study in the United States. The following information provides an overview of the study. For use outside the United States, please go to the international tab for international ACT information. 

A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency.

 

The purpose of this trial is to demonstrate the safety and effectiveness of using the Adjustable Continence Therapy (ACT) to provide a clinically relevant improvement in stress urinary incontinence.

Enrollment is expected to begin in the Spring of 2020 at sites across the United States. 

For additional information regarding the ACT study please visit

https://clinicaltrials.gov/ct2/show/NCT04248283

ACT-US-20-003

1840 BERKSHIRE LN N

PLYMOUTH, MN 55441

763-694-9880

  • Facebook
  • Twitter
  • YouTube